5Simmonds P,Bukh J,Combet C,et al.Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes[J].Hepatology,2005,42(4):962-973.
6Nakano T,Lu L,He Y,et al.Population genetic history of hepatitis C virus lb infection in China[J].J Gen ViroL,2006,87(Pt 1):73-82.
7Huang Z,Murray MG,Secrist JA.Recent development of therapeutics for chronic HCV infection[J].Antiviral Res,2006,71(2/3):351-362.
5[1]Alberit A, Benvegnu L. Management of hepatitis C. J Hepatol,2003,38(suppl 1): S1014 ～ S118
6[2]Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut,2001,49(Suppl Ⅰ) :S1 ～ S12
7[3]Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribvirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. Gut, 2002,51: 864 ～ 869
8[4]Chander G, Sulkowski MS, Jenckes MW. et al. Treatment of chronic hepatitis C: a systemic review. Hepatology, 2002,36 (5 suppl 1 ):S135 ～ S144
9[5]DiCiommo V, Russo P, Rave L, et al. Interferon alpha in the treatment of chronic hepatits C in children: a meta-analysis. J Viral Hepat,2003, 10:210 ～ 214
10[6]Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther,2003,18:1071 ～ 1081
